Deucravacitinib versus placebo in adults with moderate-to-severe hidradenitis suppurativa: A pilot study. // JAAD International. – URL: https://www.sciencedirect.com/science/article/pii/S2666328726001562?dgcid=rss_sd_all
Deucravacitinib versus placebo in adults with moderate-to-severe hidradenitis suppurativa: A pilot study. JAAD International. https://www.sciencedirect.com/science/article/pii/S2666328726001562?dgcid=rss_sd_all
“Deucravacitinib versus placebo in adults with moderate-to-severe hidradenitis suppurativa: A pilot study.” JAAD International.
@article{article50649,
title = {Deucravacitinib versus placebo in adults with moderate-to-severe hidradenitis suppurativa: A pilot study},
journal = {JAAD International},
url = {https://www.sciencedirect.com/science/article/pii/S2666328726001562?dgcid=rss_sd_all}
}